Association of Changes in Portal Insulin with Immunometabolism During and After Hepatitis C Virus Infection
Matthew G. Menkart, Jenna L. Oringher, Moumita Chakraborty, James A. Haddad, Gabriella M. Quinn, Grace Zhang, Elizabeth C. Townsend, Kareen L. Akiva, Lisa Scheuing, Anjali Rai, Shakuntala Rampertaap, Sergio D. Rosenzweig, Christopher Koh, Rebecca J Brown, Regina Umarova, Elliot B. Levy, David E. Kleiner, Rabab O. Ali, Ohad Etzion, Rownock Afruza, Theo Heller
[ Html ]
[ PDF ] 245-257
doi:10.14218/JCTH.2025.00498
Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China
Jinlin Hou, Qin Ning, Zhongping Duan, Yu Chen, Qing Xie, Lunli Zhang, Shanming Wu, Hong Tang, Jun Li, Feng Lin, Yongfeng Yang, Guozhong Gong, Yanwen Luo, Yan Chen, Frida Abramov, Leland J. Yee, Hongyuan Wang, Roberto Mateo, Tahmineh Yazdi, Irina Botros, Chengwei Chen, Yan Huang, Mingxiang Zhang, Jidong Jia
[ Html ]
[ PDF ] 146-158
doi:10.14218/JCTH.2025.00438
Intestinal Candida albicans is Associated with Subclinical Coronary Atherosclerosis in Metabolic Dysfunction-associated Steatotic Liver Disease with Cirrhosis
Nantawat Satthawiwat, Suthida Visedthorn, Pakorn Ruengket, Prangwalai Chanchaem, Pattida Kongsomboonchoke, Monravee Tumkosit, Pairoj Chattranukulchai, Sunchai Payungporn, Pisit Tangkijvanich
[ Html ]
[ PDF ] 269-279
doi:10.14218/JCTH.2025.00507
Metabolic Risk Factors and Clinical Presentations of Metabolic Dysfunction-associated Steatotic Liver Disease Using Data from the All of Us Research Program
Ke-Qin Hu, Seyedeh Neelufar Payrovnaziri, Argyrios Ziogas, Steven Hiek, Kuangda Shan, Tevan Luong, Jenny Fang, Hoda Anton-Culver
[ Html ]
[ PDF ] 137-145
doi:10.14218/JCTH.2025.00393
Risk Factors and Biomarkers for Immune Checkpoint Inhibitor-mediated Hepatotoxicity: Emerging Insights and Future Perspectives
Zaoqin Yu, Yanjiao Xu, Wei Li, Yingjie Hu, Chengliang Zhang
[ Html ]
[ PDF ] 215-231
doi:10.14218/JCTH.2025.00622
Cathepsin K Alleviates Liver Fibrosis by Inhibiting the TGF-β/Smad Signaling Pathway and Inducing Hepatic Stellate Cell Apoptosis
Zhandong Lin, Yue Shi, Mengjiao Sun, Jiawei Cui, Dandan Zhao, Yaoyao Mao, Congyue Zhang, Ying Zhang, Qianqian Zheng, Yukai Chen, Shaoya Li, Yuemin Nan
[ Html ]
[ PDF ] 187-201
doi:10.14218/JCTH.2025.00592
Repurposing SGLT2 Inhibitors for Cirrhotic Ascites: From Mechanistic Research to Clinical Exploration
Yuan Gao, Yunyi Gao, Dong Ji, Zhongjie Hu
[ Html ]
[ PDF ] 232-239
doi:10.14218/JCTH.2025.00465
Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy
Bin Niu, Jun Xu, Liaoyun Zhang
[ Html ]
[ PDF ] 202-214
doi:10.14218/JCTH.2025.00401
Immune Checkpoint Inhibitor–induced Liver Injury: A Critical Appraisal of Treatment and Rechallenge Controversies
Fernando Bessone, Nelia Hernandez
[ Html ]
[ PDF ] 240-244
doi:10.14218/JCTH.2025.00450
Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes
Yue-Yang Ma, Wei-Hao Zhao, Ke-Ying Ou, Jia-Nan Cui, Chuan-Su Yuan, Bin Liu, Yong-Feng Yang, Qing-Fang Xiong
[ Html ]
[ PDF ] 23-30
doi:10.14218/JCTH.2025.00424
Primary Biliary Cholangitis–associated Osteoporosis: Contemporary Review of Pathogenesis and Management
Jiaqi Yang, Shuhao Su, Ting Yuan, Caiyun Yang, Jie Luo, Xingchen Liu, Guanya Guo, Changcun Guo, Ying Han
[ Html ]
[ PDF ] 76-82
doi:10.14218/JCTH.2025.00505